BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li M, Shen Z, Li YM. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. World J Gastroenterol 2013; 19(41): 7024-7031 [PMID: 24222944 DOI: 10.3748/wjg.v19.i41.7024] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Choi JM, Park HE, Han YM, Lee J, Lee H, Chung SJ, Lim SH, Yim JY, Chung GE. Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness. Front Med 2022;9:844954. [DOI: 10.3389/fmed.2022.844954] [Reference Citation Analysis]
2 Han YM, Lee J, Choi JM, Kwak MS, Yang JI, Chung SJ, Yim JY, Chung GE. The association between Helicobacter pylori with nonalcoholic fatty liver disease assessed by controlled attenuation parameter and other metabolic factors. PLoS One 2021;16:e0260994. [PMID: 34898613 DOI: 10.1371/journal.pone.0260994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang J, Dong F, Su H, Zhu L, Shao S, Wu J, Liu H. H. pylori is related to NAFLD but only in female: A Cross-sectional Study. Int J Med Sci 2021;18:2303-11. [PMID: 33967606 DOI: 10.7150/ijms.50748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Rakha M, Saleh O, Abdelgawad MS, El Baiomy A. Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-020-00071-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 李 婷. The Mechanism of Nonalcoholic Fatty Liver Disease Induced by Helicobacter pylori Infection. ACM 2021;11:3865-3869. [DOI: 10.12677/acm.2021.119566] [Reference Citation Analysis]
6 Gupta E, Mahajan S, Khurana J, Rastogi A. Association between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease. Journal of Gastrointestinal Infections 2019;9:5-9. [DOI: 10.5005/jp-journals-10068-3025] [Reference Citation Analysis]
7 Maharshi V, Gupta P, Kumar VL, Upadhyay AD, Das P, Yadav R, Nayak B, Kumar R, Shalimar. Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized-controlled pilot study. Gastroenterol Rep (Oxf) 2020;8:104-10. [PMID: 32499918 DOI: 10.1093/gastro/goz058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Tang DM, Chascsa DM, Chou JY, Ho N, Auh S, Wank SA, Koh C, Kumar S. Helicobacter pyloriinfection is strongly associated with metabolic syndrome, and weakly associated with non‐alcoholic fatty liver disease, in a US Hispanic population. GastroHep 2019;1:325-331. [DOI: 10.1002/ygh2.375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mohammadifard M, Saremi Z, Rastgoo M, Akbari E. Relevance between Helicobacter pylori Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran. J Med Life 2019;12:168-72. [PMID: 31406519 DOI: 10.25122/jml-2019-0012] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Yu LY, Hu KC, Liu CJ, Hung CL, Bair MJ, Chen MJ, Wang HY, Wu MS, Shih SC, Liu CC. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque. Medicine (Baltimore) 2019;98:e14672. [PMID: 30817593 DOI: 10.1097/MD.0000000000014672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Huang B, Yan S, Chen C, Ye S. Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes. Wien Klin Wochenschr 2019;131:75-80. [PMID: 30542778 DOI: 10.1007/s00508-018-1416-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 He C, Cheng D, Wang H, Wu K, Zhu Y, Lu N. Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice. Clinics and Research in Hepatology and Gastroenterology 2018;42:360-7. [DOI: 10.1016/j.clinre.2017.12.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 German SV, Bobrovnitsky IP. Helicobacter pylori Infection and Hepatobiliary Pathology. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2018;28:15-22. [DOI: 10.22416/1382-4376-2018-28-4-15-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Kang SJ, Kim HJ, Kim D, Ahmed A. Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States. PLoS One 2018;13:e0202325. [PMID: 30110395 DOI: 10.1371/journal.pone.0202325] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
15 Fan N, Peng L, Xia Z, Zhang L, Wang Y, Peng Y. Helicobacter pylori Infection Is Not Associated with Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study in China. Front Microbiol 2018;9:73. [PMID: 29445363 DOI: 10.3389/fmicb.2018.00073] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
16 Omodele-lucien A, Goren I. Extragastric Gastrointestinal Manifestations of Helicobacter Pylori: Friend or Foe? EMJ Gastroenterol 2017. [DOI: 10.33590/emjgastroenterol/10313313] [Reference Citation Analysis]
17 Kim TJ, Sinn DH, Min YW, Son HJ, Kim JJ, Chang Y, Baek SY, Ahn SH, Lee H, Ryu S. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease. J Gastroenterol 2017;52:1201-10. [PMID: 28382402 DOI: 10.1007/s00535-017-1337-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 9.4] [Reference Citation Analysis]
18 Cherkas A, Eckl P, Gueraud F, Abrahamovych O, Serhiyenko V, Yatskevych O, Pliatsko M, Golota S. Helicobacter pylori in sedentary men is linked to higher heart rate, sympathetic activity, and insulin resistance but not inflammation or oxidative stress. Croat Med J 2016;57:141-9. [PMID: 27106356 DOI: 10.3325/cmj.2016.57.141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
19 Tang DM, Kumar S. The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease. Curr Gastroenterol Rep 2017;19:5. [PMID: 28155087 DOI: 10.1007/s11894-017-0545-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
20 Lecube A, Valladares S, López-Cano C, Gutiérrez L, Ciudin A, Fort JM, Reñé JM, Matias-Guiu X, de Torres I, Bueno M, Pallarés J, Baena JA. The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. PLoS One 2016;11:e0166741. [PMID: 27893763 DOI: 10.1371/journal.pone.0166741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
21 Baeg MK, Yoon SK, Ko SH, Noh YS, Lee IS, Choi MG. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease. World J Gastroenterol 2016; 22(8): 2592-2600 [PMID: 26937147 DOI: 10.3748/wjg.v22.i8.2592] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
22 Rabelo-Gonçalves EM, Roesler BM, Zeitune JM. Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases. World J Hepatol 2015; 7(30): 2968-2979 [PMID: 26730276 DOI: 10.4254/wjh.v7.i30.2968] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
23 Waluga M, Kukla M, Żorniak M, Bacik A, Kotulski R. From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol 2015; 7(18): 2136-2146 [PMID: 26328025 DOI: 10.4254/wjh.v7.i18.2136] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
24 Bahadoran Z, Mirmiran P, Zarif-Yeaganeh M, Zojaji H, Azizi F. Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients. Endocrinol Metab (Seoul). 2015;30:280-287. [PMID: 26435133 DOI: 10.3803/EnM.2015.30.3.280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Dai YN, Yu WL, Zhu HT, Ding JX, Yu CH, Li YM. Is Helicobacter pylori infection associated with glycemic control in diabetics? World J Gastroenterol 2015; 21(17): 5407-5416 [PMID: 25954115 DOI: 10.3748/wjg.v21.i17.5407] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
26 Zhang SR, Fan XM. Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2015; 21(11): 3214-3222 [PMID: 25805927 DOI: 10.3748/wjg.v21.i11.3214] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
27 Sumida Y, Kanemasa K, Imai S, Mori K, Tanaka S, Shimokobe H, Kitamura Y, Fukumoto K, Kakutani A, Ohno T, Taketani H, Seko Y, Ishiba H, Hara T, Okajima A, Yamaguchi K, Moriguchi M, Mitsuyoshi H, Yasui K, Minami M, Itoh Y. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J Gastroenterol 2015;50:996-1004. [PMID: 25622927 DOI: 10.1007/s00535-015-1039-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]